MTARC1 Gene

Name mitochondrial amidoxime reducing component 1
Description Enables molybdenum ion binding activity; molybdopterin cofactor binding activity; and oxidoreductase activity, acting on other nitrogenous compounds as donors. Contributes to nitrite reductase (NO-forming) activity. Involved in cellular detoxification of nitrogen compound; nitrate metabolic process; and nitric oxide biosynthetic process. Located in mitochondrion. Part of nitric-oxide synthase complex. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMTARC1 is a mitochondrial molybdenum‐dependent enzyme that functions as the catalytic unit in an electron transfer system. In multiple studies, it has been shown to reduce a variety of N‑hydroxylated substrates – including amidoximes used as prodrugs – and to catalyze the reduction of nitrite and nitric oxide intermediates such as NOHA. This capacity depends on its molybdenum cofactor and proper coordination at critical active‐site residues, with reaction rates that can be modulated by factors like pH. These biochemical activities highlight MTARC1’s role in both drug bioactivation and nitric oxide signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructurally, MTARC1 is anchored in the outer mitochondrial membrane with its catalytic domain exposed to the cytosol. Its activity is tightly linked to partner proteins such as cytochrome b5 (particularly the mitochondrial isoform) and NADH‐cytochrome b5 reductase that supply reducing equivalents. Although MTARC1 shares homology with other molybdenum enzymes, it behaves as a monomer and is assembled into large protein complexes. Detailed kinetic studies have further characterized how subtle changes—in particular in regions surrounding the catalytic site—can impact cofactor binding and electron transfer, thereby modulating overall enzyme performance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic studies have now established that common variants in the MTARC1 gene—most notably the p.Ala165Thr substitution—are associated with a reduced risk of liver diseases such as cirrhosis, non‐alcoholic fatty liver disease, and metabolic dysfunction–associated steatotic liver disease. Population‐based investigations and functional analyses in both human cells and preclinical models indicate that this variant decreases MTARC1 protein stability, leads to aberrant subcellular localization, and diminishes N‑reductive enzyme activity. In addition, outcomes related to circulating lipid profiles and liver inflammation have been favorably modulated by this variant in pediatric, adult, and bariatric populations, with further investigations in autoimmune and alcohol‐related liver disease underscoring the broader clinical impact. Collectively, these findings suggest that reduced MTARC1 function is protective, and that its modulation represents a promising target for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sanja Gruenewald, Bettina Wahl, Florian Bittner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/jm8010417"}], "href": "https://doi.org/10.1021/jm8010417"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19053771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19053771"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Bettina Wahl, Debora Reichmann, Dimitri Niks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.169532"}], "href": "https://doi.org/10.1074/jbc.M110.169532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20861021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20861021"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jürke Kotthaus, Bettina Wahl, Antje Havemeyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20100960"}], "href": "https://doi.org/10.1042/BJ20100960"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21029045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21029045"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alejandro Chamizo-Ampudia, Aurora Galvan, Emilio Fernandez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Chlamydomonas reinhardtii molybdenum cofactor enzyme crARC has a Zn-dependent activity and protein partners similar to those of its human homologue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eukaryot Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/EC.05096-11"}], "href": "https://doi.org/10.1128/EC.05096-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21803866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21803866"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Courtney E Sparacino-Watkins, Jesús Tejero, Bin Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.555177"}], "href": "https://doi.org/10.1074/jbc.M114.555177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24500710"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24500710"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Julian M Klein, Jakob D Busch, Christoph Potting, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.419424"}], "href": "https://doi.org/10.1074/jbc.M112.419424"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23086957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23086957"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Birte Plitzko, Gudrun Ott, Debora Reichmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.474916"}], "href": "https://doi.org/10.1074/jbc.M113.474916"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23703616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23703616"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Gudrun Ott, Debora Reichmann, Cornelia Boerger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.113.055202"}], "href": "https://doi.org/10.1124/dmd.113.055202"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24423752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24423752"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Connor A Emdin, Mary E Haas, Amit V Khera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1008629"}], "href": "https://doi.org/10.1371/journal.pgen.1008629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32282858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32282858"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hamish Innes, Stephan Buch, Sharon Hutchinson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2020.06.014"}], "href": "https://doi.org/10.1053/j.gastro.2020.06.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32561361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32561361"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Carolin V Schneider, Kai Markus Schneider, Donna M Conlon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genome-first approach to mortality and metabolic phenotypes in "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MTARC1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " p.Ala165Thr (rs2642438) heterozygotes and homozygotes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.medj.2021.04.011"}], "href": "https://doi.org/10.1016/j.medj.2021.04.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34258604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34258604"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Maciej K Janik, Wiktor Smyk, Beata Kruk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-021-03521-3"}], "href": "https://doi.org/10.1038/s41598-021-03521-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34949757"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34949757"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Christian A Hudert, Leon A Adams, Anna Alisi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatol Commun (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep4.1955"}], "href": "https://doi.org/10.1002/hep4.1955"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35411667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35411667"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Berenice Rivera-Paredez, Diana I Aparicio-Bautista, Anna D Argoty-Pantoja, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MARC1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": ", "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "ADCY5,"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "BCO1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Variants with the Lipid Profile, Suggests an Additive Effect for Hypertriglyceridemia in Mexican Adult Men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms231911815"}], "href": "https://doi.org/10.3390/ijms231911815"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36233117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36233117"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Piotr Kalinowski, Wiktor Smyk, Małgorzata Nowosad, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MTARC1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "HSD17B13"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms232415825"}], "href": "https://doi.org/10.3390/ijms232415825"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36555467"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36555467"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Mengyue Wu, Meng Tie, Liwei Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2024.149655"}], "href": "https://doi.org/10.1016/j.bbrc.2024.149655"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38340654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38340654"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.15857"}], "href": "https://doi.org/10.1111/liv.15857"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38375985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38375985"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Eriks Smagris, Lisa M Shihanian, Ivory J Mintah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1011179"}], "href": "https://doi.org/10.1371/journal.pgen.1011179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38437227"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38437227"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Amanda K Jones, Besnik Bajrami, Morgan K Campbell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatol Commun (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/HC9.0000000000000365"}], "href": "https://doi.org/10.1097/HC9.0000000000000365"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38619429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38619429"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Wangfang Hou, Christian Watson, Ted Cecconie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2024.107353"}], "href": "https://doi.org/10.1016/j.jbc.2024.107353"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38723751"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38723751"}]}]}]}
NCBI Gene ID 64757
API
Download Associations
Predicted Functions View MTARC1's ARCHS4 Predicted Functions.
Co-expressed Genes View MTARC1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MTARC1's ARCHS4 Predicted Functions.

Functional Associations

MTARC1 has 1,786 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 33 datasets.

Click the + buttons to view associations for MTARC1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MTARC1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of MTARC1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Proteomics Cell lines associated with MTARC1 protein from the CCLE Cell Line Proteomics dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of MTARC1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing MTARC1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing MTARC1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with MTARC1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of MTARC1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by MTARC1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
GO Biological Process Annotations 2023 biological processes involving MTARC1 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving MTARC1 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2023 cellular components containing MTARC1 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing MTARC1 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by MTARC1 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by MTARC1 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of MTARC1 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of MTARC1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of MTARC1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with MTARC1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by MTARC1 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of MTARC1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of MTARC1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of MTARC1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of MTARC1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MTARC1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of MTARC1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
Reactome Pathways 2024 pathways involving MTARC1 protein from the Reactome Pathways 2024 dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of MTARC1 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of MTARC1 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of MTARC1 gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of MTARC1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of MTARC1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with MTARC1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.